These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31940910)

  • 1. Chemistry and Some Biological Potential of Bismuth and Antimony Dithiocarbamate Complexes.
    Adeyemi JO; Onwudiwe DC
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31940910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group VA Aromatic Thiosemicarbazone Complexes: Synthesis, Characterization, Biological Activity, and Topological Studies.
    Ozturk II; Sumer EI; Dutkiewicz G; Banti CN; Hadjikakou SK; Grześkiewicz AM; Kubicki M
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elaborated 1H NMR study for the ligitional behavior of two thiosemicarbazide derivatives towards some heavy metals (Sn(II), Sb(III), Pb(II) and Bi(III)), thermal, antibacterial and antifungal studies.
    el-Metwaly NM; Refat MS
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Oct; 81(1):519-28. PubMed ID: 21767980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of bismuth(III) and antimony(V) porphyrins: high antileishmanial activity against antimony-resistant parasite.
    Gomes ML; DeFreitas-Silva G; dos Reis PG; Melo MN; Frézard F; Demicheli C; Idemori YM
    J Biol Inorg Chem; 2015 Jul; 20(5):771-9. PubMed ID: 25929728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved antileishmanial activity of Dppz through complexation with antimony(III) and bismuth(III): investigation of the role of the metal.
    Lizarazo-Jaimes EH; Monte-Neto RL; Reis PG; Fernandes NG; Speziali NL; Melo MN; Frézard F; Demicheli C
    Molecules; 2012 Oct; 17(11):12622-35. PubMed ID: 23099618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural influences on the activity of bismuth(III) indole-carboxylato complexes towards Helicobacter pylori and Leishmania.
    Pathak A; Blair VL; Ferrero RL; Kedzierski L; Andrews PC
    J Inorg Biochem; 2017 Dec; 177():266-275. PubMed ID: 28583712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Research Trends on Bismuth Compounds in Cancer Chemoand Radiotherapy.
    Kowalik M; Masternak J; Barszcz B
    Curr Med Chem; 2019; 26(4):729-759. PubMed ID: 28971764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.
    Andrews PC; Blair VL; Ferrero RL; Junk PC; Kedzierski L; Peiris RM
    Dalton Trans; 2014 Jan; 43(3):1279-91. PubMed ID: 24190067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative stability, toxicity and anti-leishmanial activity of triphenyl antimony(v) and bismuth(v) α-hydroxy carboxylato complexes.
    Duffin RN; Blair VL; Kedzierski L; Andrews PC
    Dalton Trans; 2018 Jan; 47(3):971-980. PubMed ID: 29260831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do bismuth complexes hold promise as antileishmanial drugs?
    Ong YC; Kedzierski L; Andrews PC
    Future Med Chem; 2018 Jul; 10(14):1721-1733. PubMed ID: 29961352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of DFT methods for predicting geometries and NMR spectra of Bi(III) dithiocarbamate complexes with antitumor properties.
    de Barros Leite NF; Marques RB; Macedo-Filho A; Rocha GB; Martins EPS
    J Mol Model; 2024 May; 30(6):177. PubMed ID: 38775913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and characterization of novel antimony (III) and bismuth (III) derivatives containing β-enamino ester along with antimicrobial evaluation, DFT calculation, and cytotoxic study.
    Sangwan R; Beniwal S; Gaur S; Sharma P; Mittal M; Sharma P; Sharma J
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23548. PubMed ID: 37867459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of bismuth(III) dithiocarbamate derivatives by promoting a mitochondrial-dependent apoptotic pathway and suppressing MCF-7 breast adenocarcinoma cell invasion.
    Chan PF; Ang KP; Hamid RA
    J Biol Inorg Chem; 2024 Mar; 29(2):217-241. PubMed ID: 38369679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.
    Islam A; Rodrigues BL; Marzano IM; Perreira-Maia EC; Dittz D; Paz Lopes MT; Ishfaq M; Frézard F; Demicheli C
    Eur J Med Chem; 2016 Feb; 109():254-67. PubMed ID: 26774931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on the pharmacological profile of 2,6-diacetylpyridine bis(benzoylhydrazone) derivatives and their antimony(III) and bismuth(III) complexes.
    Ferraz KS; Silva NF; da Silva JG; de Miranda LF; Romeiro CF; Souza-Fagundes EM; Mendes IC; Beraldo H
    Eur J Med Chem; 2012 Jul; 53():98-106. PubMed ID: 22520151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nine-coordinated bismuth(III) complex derived from pentadentate 2,6-diacetylpyridine bis((4)N-methylthiosemicarbazone): crystal structure and both in vitro and in vivo biological evaluation.
    Li MX; Yang M; Niu JY; Zhang LZ; Xie SQ
    Inorg Chem; 2012 Nov; 51(22):12521-6. PubMed ID: 23136979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetra-(
    Ma T; Yang P; Dammann I; Lin Z; Mougharbel AS; Li MX; Adǎscǎliţei F; Mitea R; Silvestru C; Thorstenson C; Ullrich MS; Cseh K; Jakupec MA; Keppler BK; Donalisio M; Cavalli R; Lembo D; Kortz U
    Inorg Chem; 2020 Mar; 59(5):2978-2987. PubMed ID: 32037809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of bismuth(III) and antimony(III) calixarene complexes.
    Liu L; Zakharov LN; Golen JA; Rheingold AL; Hanna TA
    Inorg Chem; 2008 Dec; 47(23):11143-53. PubMed ID: 19228025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance assessment of semiempirical molecular orbital methods in the structural prediction of Sb(III) and Bi(III) complexes.
    Martins EP; Rocha GB
    J Mol Model; 2013 Oct; 19(10):4575-84. PubMed ID: 23959395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual anticancer and antibacterial activities of bismuth compounds based on asymmetric [NN'O] ligands.
    Marzano IM; Tomco D; Staples RJ; Lizarazo-Jaimes EH; Gomes DA; Bucciarelli-Rodriguez M; Guerra W; de Souza ÍP; Verani CN; Pereira Maia EC
    J Inorg Biochem; 2021 Sep; 222():111522. PubMed ID: 34218087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.